Hydroxycarbamide Arrow (Hydroxycarbamide)

Hydroxycarbamide inhibits the enzyme ribonucleotide reductase, which is essential for producing deoxyribonucleotides needed for DNA synthesis. By limiting the supply of these building blocks, the drug impairs replication of rapidly dividing cells, particularly abnormal hematopoietic and leukemic cells, thereby reducing disease activity.

The dosage of Hydroxycarbamide Arrow is individualized and set by the prescribing clinician based on the patient’s condition, age, weight, and laboratory parameters. Physicians determine the appropriate dose and titration schedule, and patients should follow the specific instructions provided by their healthcare professional.

Hydroxycarbamide is generally avoided during pregnancy and lactation because of potential risks to the fetus or infant. If treatment is considered essential, the benefits must outweigh the risks and a specialist should be consulted. Women of child‑bearing potential should use effective contraception while on therapy.

To place an order, submit an enquiry on the Hydroxycarbamide Arrow product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Hydroxycarbamide Arrow belongs to the antimetabolite class and is comparable to hydroxyurea, which shares the same active ingredient. Compared with other cytoreductive agents such as busulfan or interferon, hydroxycarbamide offers oral administration, a well‑characterized safety profile, and effectiveness in both sickle cell disease and myeloproliferative disorders.

Hydroxycarbamide Arrow should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Hydroxycarbamide Arrow is taken orally, usually with a full glass of water. It can be administered with or without food, but patients should follow their prescriber’s instructions regarding timing and any dietary considerations to optimize absorption and minimize gastrointestinal discomfort.

The most serious adverse events include aplastic anemia, severe neutropenia, and pulmonary toxicity such as interstitial lung disease. These conditions require immediate medical attention, regular laboratory monitoring, and prompt dose adjustment or discontinuation if they occur.

Hydroxycarbamide Arrow should not be used by patients with known hypersensitivity to hydroxycarbamide, those with severe bone‑marrow failure, active uncontrolled infections, or significant renal or hepatic impairment without appropriate dose adjustment. Pregnant or breastfeeding women should avoid it unless a specialist determines that the benefits outweigh the risks.